我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
6
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
4
66.7%
招募中
2
33.3%
暂无批准数据
- Bengaluru-based Mestastop Solutions has applied to CDSCO for approval of a Phase II clinical trial to delay metastasis in colorectal cancer patients following surgery or chemotherapy. - The randomized controlled, double-blind trial will involve 60 patients and is expected to run for at least two years, with patient recruitment beginning upon approval. - Mestastop's approach focuses on preventing cancer cells from colonizing secondary sites, potentially transforming cancer treatment paradigms from damage control to disease containment.
